Qingsong Liu, PhD

Dr. Qingsong Liu brings more than two decades of scientific and translational research experience across chemical biology, oncology, and high-field instrumentation. His career includes research appointments at Harvard Medical School and the Dana-Farber Cancer Institute, where he contributed to technology-enabled cancer discovery. At Precedo, he leads the company’s scientific strategy, integrating advanced instrumentation with translational research platforms to drive innovation.

▪ 20+ years of scientific and translational research experience

▪ Expertise in chemical biology, oncology, and high-field technologies

▪ Research roles at Harvard Medical School and Dana-Farber Cancer Institute

▪ Ph.D., Chemistry, Texas A&M University